VIVOLUX AB has a total of 60 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2010. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are LOHOCLA RES CORPORATION, BAGO SA LABOR and ZIBO BIOPOLAR CHANGSHENG PHARMACEUTICAL CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | China | 5 | |
#4 | United States | 5 | |
#5 | Australia | 4 | |
#6 | Canada | 4 | |
#7 | Singapore | 4 | |
#8 | Brazil | 3 | |
#9 | EAPO (Eurasian Patent Organization) | 3 | |
#10 | Hungary | 3 | |
#11 | Israel | 3 | |
#12 | Republic of Korea | 3 | |
#13 | Mexico | 3 | |
#14 | South Africa | 3 | |
#15 | Hong Kong | 2 | |
#16 | Chile | 1 | |
#17 | New Zealand | 1 | |
#18 | Sweden | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement | |
#4 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Heterocyclic compounds | |
#3 | Therapeutic chemical compounds | |
#4 | Measuring microorganism processes | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Linder Stig | 49 |
#2 | Larsson Rolf | 33 |
#3 | Stig Linder | 6 |
#4 | Rolf Larsson | 5 |
#5 | Fryknaes Maarten | 4 |
#6 | Fryknäs Mårten | 4 |
#7 | Brnjic Slavica | 3 |
#8 | Fryknas Marten | 3 |
#9 | Nygren Peter | 2 |
#10 | Gullbo Joakim | 2 |
Publication | Filing date | Title |
---|---|---|
CN108431003A | Pharmaceutical composition, preparation method and use containing indole derivatives | |
EP2900667A1 | Means and method for treating solid tumours | |
SG11201401608PA | Method for inhibition of deubiquitinating activity | |
US2013079370A1 | Method for the Inhibition of Deubiquitinating Activity | |
EP2756310A1 | Proteasome deubiquitinating inhibitor screening | |
EA025180B1 | Treatment of solid tumours | |
CN102770137A | Tumour treatment agents and method |